563.1000 -4.45 (-0.78%)
NSE Jun 19, 2026 15:31 PM
Volume: 127.7K
 

563.10
-0.78%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma has gained 25.08% in the last 3 Months
More from Solara Active Pharma Sciences Ltd.
Recommended